InvestSMART

Nexalis Therapeutics Ltd (ASX: NX1) - Announcements

- Current share price for NX1 : $0.015

ASX company news and announcements for Nexalis Therapeutics Ltd (NX1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nexalis Therapeutics Ltd (NX1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nexalis Therapeutics Ltd (NX1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nexalis Therapeutics Ltd (NX1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Chair Appointment/Resignation 2 Oct 2026 10:01AM $0.015 $0.015 fallen by 0%
$4 Removal of draft wording in the directors report HY accounts 1 Sep 2026 3:46PM $0.009 $0.015 risen by 66.67%
$4 Half Yearly Report and Accounts 31 Aug 2026 5:57PM $0.009 $0.015 risen by 66.67%
$4 Jun26 Appendix 4C Cash Flow Report 31 Jul 2026 1:07PM $0.011 $0.015 risen by 36.36%
$4 Jun26 Quarterly Activities Report 31 Jul 2026 1:06PM $0.011 $0.015 risen by 36.36%
$4 Change in substantial holding 30 Jul 2026 11:02AM $0.011 $0.015 risen by 36.36%
$4 Change of Director's Interest Notice - Sean Williams 14 Jul 2026 3:13PM $0.010 $0.015 risen by 50%
$4 Change of Director's Interest Notice - Darryl Davies 14 Jul 2026 3:12PM $0.010 $0.015 risen by 50%
$4 Notification of cessation of securities - NX1 14 Jul 2026 3:10PM $0.010 $0.015 risen by 50%
$4 Notification regarding unquoted securities - NX1 14 Jul 2026 3:10PM $0.010 $0.015 risen by 50%
$4 Issue of director share rights post shareholder approval 14 Jul 2026 3:06PM $0.010 $0.015 risen by 50%
$4 Update on Funding Facility and Clinical Program 6 Jul 2026 11:48AM $0.010 $0.015 risen by 50%
$4 Director Appointment/Resignation 25 Jun 2026 3:52PM $0.018 $0.015 fallen by 16.67%
$4 2026 AGM results 29 May 2026 6:23PM $0.023 $0.015 fallen by 34.78%
$4 2026 AGM slides 29 May 2026 4:14PM $0.023 $0.015 fallen by 34.78%
$4 Reinstatement to Official Quotation 28 May 2026 9:48AM $0.025 $0.015 fallen by 40%
$4 Binding Letter of Intent to replace existing $53m facility 28 May 2026 9:48AM $0.025 $0.015 fallen by 40%
$4 Suspension from Quotation 26 May 2026 10:34AM $0.025 $0.015 fallen by 40%
$4 Trading Halt 22 May 2026 9:38AM $0.025 $0.015 fallen by 40%
$4 Phase 1 IRX-616a Last Patient Last Dose 14 May 2026 11:33AM $0.022 $0.015 fallen by 31.82%
$4 Director Appointment/Resignation 13 May 2026 1:10PM $0.021 $0.015 fallen by 28.57%
$4 2026 AGM - Sample Proxy Form 30 Apr 2026 5:13PM $0.022 $0.015 fallen by 31.82%
$4 2026 AGM - Access Letter 30 Apr 2026 5:12PM $0.022 $0.015 fallen by 31.82%
$4 Notice of Annual General Meeting 30 Apr 2026 5:10PM $0.022 $0.015 fallen by 31.82%
$4 Mar26 Appendix 4C Cash Flow Report 30 Apr 2026 2:40PM $0.023 $0.015 fallen by 34.78%

1 - 25 of 48 results

Page 1 of 2

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.